Your browser doesn't support javascript.
loading
Guiding principles on the education and practice of theranostics.
Pascual, Thomas N B; Paez, Diana; Iagaru, Andrei; Gnanasegaran, Gopi; Lee, Sze Ting; Sathekge, Mike; Buatti, John M; Giammarile, Francesco; Al-Ibraheem, Akram; Pardo, Manuela Arevalo; Baum, Richard P; De Bari, Berardino; Ben-Haim, Simona; Blay, Jean-Yves; Brink, Anita; Estrada-Lobato, Enrique; Fanti, Stefano; Golubic, Anja Tea; Hatazawa, Jun; Israel, Ora; Kiess, Ana; Knoll, Peter; Louw, Lizette; Mariani, Giuliano; Mirzaei, Siroos; Orellana, Pilar; Prior, John O; Urbain, Jean-Luc; Vichare, Shrikant; Vinjamuri, Sobhan; Virgolini, Irene; Scott, Andrew M.
Afiliação
  • Pascual TNB; Department of Science and Technology, Manila, Philippines.
  • Paez D; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Stanford University Medical Center, Stanford, CA, USA.
  • Gnanasegaran G; Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK.
  • Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
  • Sathekge M; Olivia Newton-John Cancer Research Institute, Melbourne, Australia.
  • Buatti JM; School of Cancer Medicine, La Trobe University, Melbourne, Australia.
  • Giammarile F; School of Health and Biomedicine, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, Australia.
  • Al-Ibraheem A; Department of Surgery, University of Melbourne, Melbourne, Australia.
  • Pardo MA; Steve Biko Academic Hospital, Pretoria, South Africa.
  • Baum RP; University of Pretoria, Pretoria, South Africa.
  • De Bari B; Department of Radiation Oncology, Holden Comprehensive Cancer Center, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Ben-Haim S; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Blay JY; Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
  • Brink A; School of Medicine, University of Jordan, Amman, Jordan.
  • Estrada-Lobato E; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Fanti S; Center for Advanced Radiomolecular Precision Oncology, Curanosticum Wiesbaden, FrankfurtWiesbaden, Germany.
  • Golubic AT; Radiation Oncology Department, Réseau Hospitalier Neuchâtelois, La Chaux-de-Fonds, Switzerland.
  • Hatazawa J; Department of Biophysics and Nuclear Medicine, Hadassah University Hospital, Jerusalem, Israel.
  • Israel O; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Kiess A; University College London, London, UK.
  • Knoll P; Department of Medicine, Centre Leon Berard, Lyon, France.
  • Louw L; University Claude Bernard Lyon, Lyon, France.
  • Mariani G; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Mirzaei S; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Orellana P; Nuclear Medicine Division, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Policlinico S.Orsola, Bologna, Italy.
  • Prior JO; Department of Nuclear Medicine and Radiation Protection, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
  • Urbain JL; Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Vichare S; B. Rappaport School of Medicine, Israel Institute of Technology-Technion, Haifa, Israel.
  • Vinjamuri S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Virgolini I; Division of Human Health, Department of Nuclear Science and Applications, International Atomic Energy Agency, Vienna, Austria.
  • Scott AM; Center of Molecular Imaging and Theranostics, Johannesburg, South Africa.
Eur J Nucl Med Mol Imaging ; 51(8): 2320-2331, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38453729
ABSTRACT

PURPOSE:

The recent development and approval of new diagnostic imaging and therapy approaches in the field of theranostics have revolutionised nuclear medicine practice. To ensure the provision of these new imaging and therapy approaches in a safe and high-quality manner, training of nuclear medicine physicians and qualified specialists is paramount. This is required for trainees who are learning theranostics practice, and for ensuring minimum standards for knowledge and competency in existing practising specialists.

METHODS:

To address the need for a training curriculum in theranostics that would be utilised at a global level, a Consultancy Meeting was held at the IAEA in May 2023, with participation by experts in radiopharmaceutical therapy and theranostics including representatives of major international organisations relevant to theranostics practice.

RESULTS:

Through extensive discussions and review of existing curriculum and guidelines, a harmonised training program for theranostics was developed, which aims to ensure safe and high quality theranostics practice in all countries.

CONCLUSION:

The guiding principles for theranostics training outlined in this paper have immediate relevance for the safe and effective practice of theranostics.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Nuclear Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Nuclear Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article